Catalog |
name |
Description |
price |
R-R-0014 |
Insulin Detemir |
Insulin Detemir/CAS No.169148-63-4 is an artificial insulin, shows effect on controlling blood sugar levels. Insulin Detemir stimulates GLP-1 secretion as a consequence of enhanced Gcg expression by a mechanism involving activation of Akt- and/or extracellular signal-regulated kinase (ERK)-dependent-cat and CREB signaling pathways. Insulin Detemir can be used for type 2 diabetes research. |
price> |
R-R-0361 |
MM-401 |
MM-401/MM 401/ MM401/CAS: 1442106-10-6 is a specific inhibitor of histone H3K4 methyltransferase MLL1 activity. It acts by reprograming mouse epiblast stem cells (EpiSCs) to naive pluripotency. |
price> |
R-R-0362 |
PD-1 |
PD-1/PD-L1-IN 3/Cas:1629654-95-0, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 can be used for the research of various diseases, including cancer and infectious diseases. |
price> |
R-R-0371 |
Cyclo(Arg-Gly-Asp-D-Phe-Val) |
Cyclo(Arg-Gly-Asp-D-Phe-Val)CAS 137813-35-5 is a potent inhibitor of cell adhesion. It prevents tumor-cell adhesion to laminin and vitronectin substrates and tubular obstruction by preventing cell-cell adhesion. In a rat model, it reduced ischemic acute renal failure. |
price> |
R-R-0377 |
Cyclo(leu-leu) |
Cyclo(leu-leu)/CAS 952-45-4/Cyclo(L-leucyl-L-leucyl) is a glycosidase inhibitor that has been shown to have an inhibitory effect on the biosynthesis of aminoacylated proteins. Cyclo (leu-leu) is derived from the wild-type strain of a fungus, which is a genus of endophytic fungi. This compound inhibits the synthesis of proteins by binding to glycosylated amino acid residues and preventing their hydrolysis. Cyclo (leu-leu) also has homologous regions with mellein, which is another type of glycosidase inhibitor that binds to the enzyme protein kinase C, inhibiting protein synthesis and leading to cell death. |
price> |
R-R-0407 |
BK-1361 |
Cyclo(RLsKDK) (BK-1361)/Cas.1975145-82-4 is a specific inhibitor of metalloproteinase ADAM8 with an IC 50 value of 182 nM. cyclo(RLsKDK) has potential applications in inflammatory diseases and cancer. |
price> |
R-R-0413 |
Pasireotide |
Pasireotide (SOM230) Cas.396091-73-9, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide also exhibits antisecretory, antiproliferative, and proapoptotic activity. |
price> |
R-R-0420 |
LY-2510924/CAS:1088715-84-7 |
LY-2510924/CAS:1088715-84-7 is an inhibitor of CXC chemokine receptor 4 (CXCR4), with potential antineoplastic activity. Upon subcutaneous administration, CXCR4 inhibitor LY2510924 binds to the chemokine receptor CXCR4, thereby preventing CXCR4 binding to its ligand, stromal derived factor-1 (SDF-1), and subsequent receptor activation. This may result in decreased tumor cell proliferation and migration. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor (GPCR) gene family, plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types. |
price> |
R-R-0481 |
Gastric Inhibitory Polypeptide (6-30) amide (human) |
Gastric Inhibitory Polypeptide (6-30) amide (human)/CAS.1139691-72-7 is an incretin hormone. Gastric Inhibitory Polypeptide (6-30) amide (human) can be used for the research of diabete. |
price> |
R-R-0488 |
Histatin-8 [Hemagglutination - Inhibiting Peptide (HIP)] |
Histatin 8, or hemagglutination inhibiting peptide (HIP)/CAS:127637-03-0 is a 12 amino acid histidine rich cationic human salivary peptide, formed with histatin 5 from post-translational cleavage of histatin 3. Histatins function as antimicrobial peptides and are important components of the innate immune system. |
price> |